TY - JOUR
T1 - Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
AU - Abughazaleh, Shaadi
AU - Safdar, Zeenat
N1 - Publisher Copyright:
© 2020 Shaadi Abughazaleh and Zeenat Safdar.
PY - 2020
Y1 - 2020
N2 - A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. Most cases of thyroid disease describe thyrotoxicosis and hyperthyroid statues, but our case was a patient on long term IV epoprostenol presenting with a superior vena cava-syndrome (SVC) like appearance and airway compromise found to have a goiter incidentally during workup.
AB - A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. Most cases of thyroid disease describe thyrotoxicosis and hyperthyroid statues, but our case was a patient on long term IV epoprostenol presenting with a superior vena cava-syndrome (SVC) like appearance and airway compromise found to have a goiter incidentally during workup.
UR - http://www.scopus.com/inward/record.url?scp=85111531064&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111531064&partnerID=8YFLogxK
U2 - 10.1155/2020/1617253
DO - 10.1155/2020/1617253
M3 - Article
AN - SCOPUS:85111531064
SN - 2090-6846
VL - 2020
JO - Case Reports in Pulmonology
JF - Case Reports in Pulmonology
M1 - 1617253
ER -